340B Is a Brake on Runaway Drug Prices

by Admin | October 3, 2016 1:52 pm

October 3, 2016—To clamp down on rising drug prices, Congress should protect the 340B drug discount program – a rare public policy initiative that helps healthcare providers and their patients, the leader of a group of more than 1,200 safety-net hospitals writes in a new op-ed for Yahoo Finance[1].  

You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register[2].    Already registered? Click here to login[3]. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)

Endnotes:
  1. a new op-ed for Yahoo Finance: http://us.finance.qa1p.global.media.yahoo.com/news/big-pharma-is-behind-an-effort-to-gut-a-little-known-drug-discount-program-174213395.html
  2. Click here to register: https://secure.340bhealth.org/340Binformed/Subscribe.aspx
  3. Click here to login: http://340binformed.org/reader-login/

Source URL: https://340binformed.org/2016/10/340b-is-a-brake-on-runaway-drug-prices/

Copyright ©2026 340binformed.org unless otherwise noted.